Enlivex Ltd.
corporate_fare Company Profile
Enlivex Ltd. (NASDAQ:ENLV) is a publicly traded company in the Crypto Assets sector. Wiseek has independently scored 44 items for ENLV at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Enlivex Reports $1.1B RAIN Token Treasury, NAV Per Share at $66.16
- Enlivex's Allocetra™ Lands FDA RMAT Designation for Knee Osteoarthritis, Paving the Way for Expedited Review
- Enlivex Announces 1-for-15 Reverse Split to Avoid Nasdaq Delisting
- Enlivex Finalizes 1-for-15 Reverse Stock Split, Effective July 9th, to Address Nasdaq Compliance
- Enlivex's RAIN Token to List on Gate Exchange, Boosting Liquidity for $1.14B Treasury
Financial Snapshot
Insider Transactions
ENLV files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.